Table of Content

Table of Contents

Global Anal and Colorectal Cancer Market Outlook-by Major Company, Regions, Type, Application and Segment Forecast, 2016-2027
1 Market Scope Anal and Colorectal Cancer
1.1 Anal and Colorectal Cancer Market Snapsshot
1.1.1 Major Companies Overview
1.1.2 Market Concentration
1.1.3 Market Share & Six-Year Compound Annual Growth Rate of Major Market (CAGR)
2 Global Anal and Colorectal Cancer Industry Analysis
2.1 Sector Breakdown Assessment, 2016-2027
2.2 Market Assessment by Type
2.3 Market Size Analysis and Forecast, by Application
3 China Anal and Colorectal Cancer Market Estimates & Forecasts
3.1 China Anal and Colorectal Cancer Market by Sector, 2015-2026
3.2 China Anal and Colorectal Cancer Market by Application, 2016-2027
4 EU Anal and Colorectal Cancer Market Estimates & Forecasts
4.1 EU Anal and Colorectal Cancer Market by Sector, 2016-2027
4.2 EU Anal and Colorectal Cancer Market by Application, 2016-2027
5 USA Anal and Colorectal Cancer Market Estimates & Forecasts
5.1 USA Anal and Colorectal Cancer Market by Sector, 2016-2027
5.2 USA Anal and Colorectal Cancer Market by Application, 2016-2027
6 Japan Anal and Colorectal Cancer Market Estimates & Forecasts
6.1 Japan Anal and Colorectal Cancer Market by Sector, 2016-2027
6.2 Japan Anal and Colorectal Cancer Market by Application, 2016-2027
7 India Anal and Colorectal Cancer Market Estimates & Forecasts
7.1 India Anal and Colorectal Cancer Market by Sector, 2016-2027
7.2 India Anal and Colorectal Cancer Market by Application, 2016-2027
8 Southeast Asia Anal and Colorectal Cancer Market Estimates & Forecasts
8.1 Southeast Asia Anal and Colorectal Cancer Market by Sector, 2016-2027
8.2 Southeast Asia Anal and Colorectal Cancer Market by Application, 2016-2027
9 South America Anal and Colorectal Cancer Market Estimates & Forecasts
9.1 South America Anal and Colorectal Cancer Market by Sector, 2016-2027
9.2 South America Anal and Colorectal Cancer Market by Application, 2016-2027
10 Value Chain (Impact of COVID-19)
10.1 Anal and Colorectal Cancer Value Chain Analysis
10.1.1 Downstream
10.2 COVID-19 Impact on this Industry
10.2.1 Industrial Policy Issued Under the Epidemic Situation
10.3 Driver
10.4 Opportunity

11 Competitive Analysis
11.1 Abbott Diagnostics
11.1.1 Key Information
11.1.2 Service/Solution Introduction
11.1.3 Financials
11.1.4 Business Dynamics
11.2 Advaxis
11.2.1 Key Information
11.2.2 Service/Solution Introduction
11.2.3 Financials
11.2.4 Business Dynamics
11.3 Abbott
11.3.1 Key Information
11.3.2 Service/Solution Introduction
11.3.3 Financials
11.3.4 Business Dynamics
11.4 Amgen
11.4.1 Key Information
11.4.2 Service/Solution Introduction
11.4.3 Financials
11.4.4 Business Dynamics
11.5 Atara Biotherapeutics
11.5.1 Key Information
11.5.2 Service/Solution Introduction
11.5.3 Financials
11.5.4 Business Dynamics
11.6 Bayer
11.6.1 Key Information
11.6.2 Service/Solution Introduction
11.6.3 Financials
11.6.4 Business Dynamics
11.7 Metabiomics
11.7.1 Key Information
11.7.2 Service/Solution Introduction
11.7.3 Financials
11.7.4 Business Dynamics
11.8 Beckman Coulter
11.8.1 Key Information
11.8.2 Service/Solution Introduction
11.8.3 Financials
11.8.4 Business Dynamics
11.9 BeiGene
11.9.1 Key Information
11.9.2 Service/Solution Introduction
11.9.3 Financials
11.9.4 Business Dynamics
11.10 Boehringer Ingelheim
11.10.1 Key Information
11.10.2 Service/Solution Introduction
11.10.3 Financials
11.10.4 Business Dynamics
11.11 Clinical Genomics
11.12 EDP Biotech
11.13 Eli Lilly
11.14 Epigenomics
11.15 Exact Sciences
11.16 Genomictree
11.17 Immunovaccine
11.18 ISA Pharmaceuticals
11.19 Merck
12 Research Conclusion

List of Figure

List of Tables and Figures

Table Revenue (Million USD) of Major Players (2015-2020)
Figure Anal and Colorectal Cancer Revenue Market Share of Top 5 Players
Table Market Share & CAGR of Major Market (2021-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Table CAGR in Terms of Revenue of Each Type (2016-2027)
Table Global Anal and Colorectal Cancer Revenue (Million USD) by Type (2016-2027)
Figure Global Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Global Anal and Colorectal Cancer Revenue Market Share (%) by Type (2019 – 2020)
Figure Market Assessment by Type
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Table China Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure China Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table US Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure US Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & ForecastAnal and Colorectal CancerDifferent Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Europe Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure Europe Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Japan Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure Japan Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Southeast Asia Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure Southeast Asia Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table South America Anal and Colorectal Cancer Market Estimates & Forecasts by Sector (2016-2027)
Figure South America Anal and Colorectal Cancer Revenue (Million USD) and Growth Rate (2016-2027)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Anal and Colorectal Cancer Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Figure Value Chain Structure of Anal and Colorectal Cancer
Table Value Chain
Table Key Downstream Customer in Each Application Field
Table Industry News List of Anal and Colorectal Cancer
Table Abbott Diagnostics Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Abbott Diagnostics (2015-2020)
Figure Abbott Diagnostics Service/Solution Introduction
Table Advaxis Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Advaxis (2015-2020)
Figure Advaxis Service/Solution Introduction
Table Abbott Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Abbott (2015-2020)
Figure Abbott Service/Solution Introduction
Table Amgen Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Amgen (2015-2020)
Figure Amgen Service/Solution Introduction
Table Atara Biotherapeutics Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Atara Biotherapeutics (2015-2020)
Figure Atara Biotherapeutics Service/Solution Introduction
Table Bayer Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Bayer (2015-2020)
Figure Bayer Service/Solution Introduction
Table Metabiomics Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Metabiomics (2015-2020)
Figure Metabiomics Service/Solution Introduction
Table Beckman Coulter Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Beckman Coulter (2015-2020)
Figure Beckman Coulter Service/Solution Introduction
Table BeiGene Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of BeiGene (2015-2020)
Figure BeiGene Service/Solution Introduction
Table Boehringer Ingelheim Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Boehringer Ingelheim (2015-2020)
Figure Boehringer Ingelheim Service/Solution Introduction
Table Clinical Genomics Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Clinical Genomics (2015-2020)
Figure Clinical Genomics Service/Solution Introduction
Table EDP Biotech Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of EDP Biotech (2015-2020)
Figure EDP Biotech Service/Solution Introduction
Table Eli Lilly Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Eli Lilly (2015-2020)
Figure Eli Lilly Service/Solution Introduction
Table Epigenomics Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Epigenomics (2015-2020)
Figure Epigenomics Service/Solution Introduction
Table Exact Sciences Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Exact Sciences (2015-2020)
Figure Exact Sciences Service/Solution Introduction
Table Genomictree Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Genomictree (2015-2020)
Figure Genomictree Service/Solution Introduction
Table Immunovaccine Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Immunovaccine (2015-2020)
Figure Immunovaccine Service/Solution Introduction
Table ISA Pharmaceuticals Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of ISA Pharmaceuticals (2015-2020)
Figure ISA Pharmaceuticals Service/Solution Introduction
Table Merck Key Information
Table Anal and Colorectal Cancer Revenue (Million USD) of Merck (2015-2020)
Figure Merck Service/Solution Introduction